cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Glaukos Corp
3 own
7 watching
Current Price
$98.23
$-1.03
(-1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,007.9M
52-Week High
52-Week High
102.33000
52-Week Low
52-Week Low
45.38000
Average Volume
Average Volume
0.33M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization4,007.9M
icon52-Week High102.33000
icon52-Week Low45.38000
iconAverage Volume0.33M
iconDividend Yield--
iconP/E Ratio--
What does the Glaukos Corp do?
Glaukos Corporation, an ophthalmic medical technology company, focuses on the development and commercialization of products and procedures designed to treat glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Inject trabecular micro-bypass stent that allows the surgeon to inject stents into various trabecular meshwork locations through a single corneal entry with the goal of achieving intraocular pressure reduction; iStent Supra suprachoroidal micro-bypass stent, which is designed to reduce intraocular pressure by accessing the suprachoroidal space in the eye; and iDose, a targeted injectable drug delivery implant that is designed to be pre-loaded into a small gauge needle and injected into the eye through a self-sealing corneal needle penetration. It markets its products through direct sales force in the United States and internationally, as well as through distribution partners in Europe, the Asia Pacific, and internationally. Glaukos Corporation was founded in 1998 and is headquartered in San Clemente, California.
Read More
How much money does Glaukos Corp make?
News & Events about Glaukos Corp.
Zolmax
10 months ago
Glaukos Co. (NYSE:GKOS Get Rating) CEO Thomas William Burns sold 17,382 shares of the stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $67.20, for a total transaction of $1,168,070.40. Following the completion of the sale, the chief executive ...
Zolmax
12 months ago
Shares of Glaukos Co. (NYSE:GKOS Get Rating) have been given a consensus rating of Hold by the eleven ratings firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and five have ...
Zolmax
12 months ago
Shares of Glaukos Co. (NYSE:GKOS Get Rating) have been assigned an average recommendation of Hold from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold ...
Ticker Report
12 months ago
Glaukos Co. (NYSE:GKOS Get Rating) has been given an average rating of Hold by the eleven ratings firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have...
Ticker Report
12 months ago
Shares of Glaukos Co. (NYSE:GKOS Get Rating) have received an average rating of Hold from the eleven ratings firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five ...
Frequently Asked Questions
Frequently Asked Questions
What is Glaukos Corp share price today?
plus_minus_icon
Can Indians buy Glaukos Corp shares?
plus_minus_icon
How can I buy Glaukos Corp shares from India?
plus_minus_icon
Can Fractional shares of Glaukos Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Glaukos Corp stocks?
plus_minus_icon
What is today’s traded volume of Glaukos Corp?
plus_minus_icon
What is today’s market capitalisation of Glaukos Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Glaukos Corp?
plus_minus_icon
What percentage is Glaukos Corp down from its 52-Week High?
plus_minus_icon
What percentage is Glaukos Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$98.23
$-1.03
(-1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00